Regulatory
FDA: From Risk Aversion to Approval Activism
During the Rutgers Business School's annual healthcare symposium, an FDA official encouraged industry to put its drugs on the reviewing table and be prepared for good news ...Read more
CEO Compensation Data
Complete salary, bonus & market capitalization data in biotech.
 www.bioworld.com
Patents
PhRMA Dismayed by Global IPR Report
The Pharmaceutical Research and Manufacturers of America (PhRMA) International Vice-President Jay Taylor has expressed the organization's concerns over the Office of the United States Trade Representative's 2013 Special 301 Report on the state of intellectual propertyrights protection and enforcement in trading partners around the world ...Read More
Patents
First 'Real' European Patent Imminent
After decades of failed attempts, by the beginning of 2014 the European Union will finally have a 'unitary patent' — a system offering a single patent valid across (nearly) all the member states ...Read more
Marketing
Time to Catch On to Content Marketing
Pharma should have a head start in the content marketing race, but familiar fears are holding it back, writes Peter Houston ...Read more
The Waiting Game: Ways to Prepare for the AMP Final Rule
Live Webcast: Tuesday, June 4, 2013 from Noon to 1:00 PM Eastern
Register Free at
 www.pharmexec.com/ampfinal
Marketing to Professionals
Pharm Exec's What Physician's Want Vol. I & II
How, when and why physicians consume information. Information on marketing, detailing, sampling, prescribing, CME, conventions and meetings from some of the best in the industry. Best methods to communicate with docs. New ideas from reorganization to alternative sales channels to embedded outsourcing ...Read more
|
